Literature DB >> 2397272

Bending studies of DNA site-specifically modified by cisplatin, trans-diamminedichloroplatinum(II) and cis-[Pt(NH3)2(N3-cytosine)Cl]+.

S F Bellon1, S J Lippard.   

Abstract

Duplex oligonucleotides containing a single intrastrand [Pt(NH3)2]2+ cross-link or monofunctional adduct and either 15 or 22 bp in length were synthesized and chemically characterized. The platinum-modified and unmodified control DNAs were polymerized in the presence of DNA ligase and the products studied on 8% native polyacrylamide gels. The extent of DNA bending caused by the various platinum-DNA adducts was revealed by their gel mobility shifts relative to unplatinated controls. The bifunctional adducts cis-[Pt(NH3)2[d(GpG)]]+, cis-[Pt(NH3)2[d(ApG)]]+, and cis-[Pt(NH3)2[d(G*pTpG*)]], where the asterisks denote the sites of platinum binding, all bend the double helix, whereas the adduct trans-[Pt(NH3)2[d(G*pTpG*)]] imparts a degree of flexibility to the duplex. When modified by the monofunctional adduct cis-[Pt(NH3)2(N3-cytosine)(dG)]Cl the helix remains rod-like. These results reveal important structural differences in DNAs modified by the antitumor drug cisplatin and its analogs that could be important in the biological processing of the various adducts in vivo.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2397272     DOI: 10.1016/0301-4622(90)80007-t

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  30 in total

1.  Thermodynamic properties of duplex DNA containing a site-specific d(GpG) intrastrand crosslink formed by an antitumor dinuclear platinum complex.

Authors:  C Hofr; N Farrell; V Brabec
Journal:  Nucleic Acids Res       Date:  2001-05-15       Impact factor: 16.971

2.  Conformation of DNA GG intrastrand cross-link of antitumor oxaliplatin and its enantiomeric analog.

Authors:  Jaroslav Malina; Olga Novakova; Marie Vojtiskova; Giovanni Natile; Viktor Brabec
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

Review 3.  Synthetic methods for the preparation of platinum anticancer complexes.

Authors:  Justin J Wilson; Stephen J Lippard
Journal:  Chem Rev       Date:  2013-11-27       Impact factor: 60.622

4.  B----Z DNA conformational changes induced by a family of dinuclear bis(platinum) complexes.

Authors:  A Johnson; Y Qu; B Van Houten; N Farrell
Journal:  Nucleic Acids Res       Date:  1992-04-11       Impact factor: 16.971

5.  Effect of geometric isomerism in dinuclear platinum antitumour complexes on the rate of formation and structure of intrastrand adducts with oligonucleotides.

Authors:  K J Mellish; Y Qu; N Scarsdale; N Farrell
Journal:  Nucleic Acids Res       Date:  1997-03-15       Impact factor: 16.971

6.  DNA interactions of antitumor cisplatin analogs containing enantiomeric amine ligands.

Authors:  J Malina; C Hofr; L Maresca; G Natile; V Brabec
Journal:  Biophys J       Date:  2000-04       Impact factor: 4.033

7.  A monofunctional platinum complex coordinated to a rhodium metalloinsertor selectively binds mismatched DNA in the minor groove.

Authors:  Alyson G Weidmann; Jacqueline K Barton
Journal:  Inorg Chem       Date:  2015-09-23       Impact factor: 5.165

8.  High-mobility-group 1 protein mediates DNA bending as determined by ring closures.

Authors:  P M Pil; C S Chow; S J Lippard
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

9.  Stereochemistry-dependent bending in oligonucleotide duplexes induced by site-specific covalent benzo[a]pyrene diol epoxide-guanine lesions.

Authors:  R Xu; B Mao; J Xu; B Li; S Birke; C E Swenberg; N E Geacintov
Journal:  Nucleic Acids Res       Date:  1995-06-25       Impact factor: 16.971

10.  Cisplatin-DNA adducts are molecular decoys for the ribosomal RNA transcription factor hUBF (human upstream binding factor).

Authors:  D K Treiber; X Zhai; H M Jantzen; J M Essigmann
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.